We are live on ! Find out more
ACM

Alethea Capital Management Portfolio holdings

AUM $195M
1-Year Est. Return 51.17%
This Fund
S&P 500
This Quarter Est. Return
+184.42%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$233M
AUM Growth
+$75.2M
Cap. Flow
-$17.9M
Cap. Flow %
-7.67%
Top 10 Hldgs %
83.44%
Holding
109
New
28
Increased
7
Reduced
15
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 49.68%
2 Financials 6.56%
3 Consumer Staples 2.63%
4 Industrials 2.51%
5 Communication Services 2.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROP icon
101
Roper Technologies
ROP
$39.3B
-1,945
Closed -$694K
SO icon
102
Southern Company
SO
$107B
-8,974
Closed -$554K
SYY icon
103
Sysco
SYY
$40.4B
-10,690
Closed -$849K
TGT icon
104
Target
TGT
$66.8B
-2,805
Closed -$300K
TRP icon
105
TC Energy
TRP
$66.6B
-4,886
Closed -$253K
UL icon
106
Unilever
UL
$137B
-4,245
Closed -$287K
XRAY icon
107
Dentsply Sirona
XRAY
$2.64B
-15,161
Closed -$808K
TWTR
108
DELISTED
Twitter, Inc.
TWTR
-10,558
Closed -$435K
VIAB
109
DELISTED
Viacom Inc. Class B
VIAB
-13,857
Closed -$333K

Similar funds

Alethea Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Alethea Capital Management held 109 positions worth $233M, up 48% from $158M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Alethea Capital Management withdrew a net $17.9M in Q4 2019, closing 24 positions and reducing 15 holdings. Its most notable exit was American Tower, an estimated $1.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Alethea Capital Management opened a new position in Universal Health Services worth $1.23M.

  • Alethea Capital Management's largest Q4 2019 buy was Universal Health Services: 8,589 shares worth $1.23M.
  • Alethea Capital Management added most to Amgen in Q4 2019, an estimated $659K increase.
  • Alethea Capital Management's biggest Q4 2019 reduction was Axsome Therapeutics, cutting an estimated $12.2M.
  • Alethea Capital Management fully exited American Tower in Q4 2019, selling an estimated $1.09M.
  • Alethea Capital Management's ten largest holdings make up 83% of its $233M portfolio in Q4 2019.
  • Alethea Capital Management opened 28 new positions and closed 24 in Q4 2019.
  • Alethea Capital Management's portfolio value rose 48% quarter-over-quarter to $233M.

Based on Alethea Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.